NCT03665519View on ClinicalTrials.gov

Clinical Trial on the Effect of the Sublimated Mare Milk Supplement on Primary Biliary Cholangitis

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 3, 2018

Primary Completion Date

September 1, 2020

Study Completion Date

December 1, 2020

Conditions
Primary Biliary Cirrhosis
Interventions
DIETARY_SUPPLEMENT

Sublimated mare milk

The dietary supplement mare milk product, which is obtained from fresh mare milk (few hours) through sublimation process.

DRUG

Ursodeoxycholic Acid

Ursodeoxycholic acid treatment will be given for 3 months.

Trial Locations (1)

010000

National Research Medical Center, Astana

All Listed Sponsors
collaborator

Eurasia Invest Ltd.

INDUSTRY

collaborator

Ministry of Education and Science, Republic of Kazakhstan

OTHER_GOV

lead

National Scientific Medical Center, Kazakhstan

OTHER_GOV

NCT03665519 - Clinical Trial on the Effect of the Sublimated Mare Milk Supplement on Primary Biliary Cholangitis | Biotech Hunter | Biotech Hunter